| Code | Description | Claims | Beneficiaries | Total Paid |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,532 |
1,524 |
$2.06M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,242 |
8,457 |
$1.65M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,450 |
8,119 |
$1.03M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,965 |
2,799 |
$917K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,137 |
4,690 |
$490K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,879 |
4,708 |
$338K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,494 |
1,451 |
$245K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,431 |
3,950 |
$225K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,203 |
2,642 |
$165K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,096 |
3,785 |
$159K |
| 71046 |
Radiologic examination, chest; 2 views |
3,665 |
3,517 |
$135K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,122 |
3,602 |
$131K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,457 |
1,444 |
$123K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,572 |
2,491 |
$114K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,822 |
1,808 |
$103K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,569 |
2,350 |
$76K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
840 |
828 |
$68K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,442 |
1,441 |
$67K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
857 |
668 |
$66K |
| 71045 |
Radiologic examination, chest; single view |
1,477 |
1,399 |
$60K |
| 80061 |
Lipid panel |
6,017 |
5,990 |
$57K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,156 |
7,931 |
$57K |
| 80053 |
Comprehensive metabolic panel |
19,559 |
17,685 |
$54K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,984 |
2,973 |
$44K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,108 |
954 |
$41K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,686 |
18,051 |
$39K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,214 |
1,176 |
$36K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
875 |
851 |
$34K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
560 |
554 |
$32K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
411 |
398 |
$31K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
285 |
280 |
$30K |
| 59025 |
Fetal non-stress test |
607 |
146 |
$30K |
| 82947 |
|
2,799 |
2,012 |
$29K |
| 99215 |
Prolong outpt/office vis |
423 |
405 |
$28K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,622 |
1,571 |
$28K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,611 |
1,561 |
$28K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
789 |
668 |
$26K |
| G0378 |
Hospital observation service, per hour |
84 |
84 |
$26K |
| 76830 |
Ultrasound, transvaginal |
370 |
364 |
$22K |
| A0425 |
Ground mileage, per statute mile |
256 |
234 |
$22K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,006 |
473 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,370 |
4,339 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
17,680 |
13,649 |
$18K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,127 |
1,124 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
743 |
717 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,676 |
4,249 |
$16K |
| 73030 |
|
927 |
842 |
$16K |
| 20610 |
|
480 |
418 |
$15K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
76 |
72 |
$15K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
765 |
764 |
$15K |
| 82607 |
|
2,140 |
2,125 |
$15K |
| 73130 |
|
999 |
831 |
$15K |
| 97162 |
|
297 |
284 |
$15K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
62 |
38 |
$14K |
| 84439 |
|
3,222 |
3,159 |
$14K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
61 |
61 |
$13K |
| 73630 |
|
979 |
896 |
$12K |
| 86900 |
|
481 |
453 |
$12K |
| 83970 |
|
625 |
613 |
$12K |
| 73610 |
|
767 |
680 |
$11K |
| 73110 |
|
597 |
483 |
$11K |
| 17110 |
|
179 |
174 |
$11K |
| 82728 |
|
1,635 |
1,588 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
749 |
737 |
$10K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
965 |
952 |
$9K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
697 |
299 |
$8K |
| 97161 |
|
200 |
198 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,976 |
2,568 |
$8K |
| 72100 |
|
307 |
304 |
$7K |
| 84481 |
|
853 |
848 |
$7K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
12 |
12 |
$6K |
| 85027 |
|
2,414 |
2,357 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,207 |
2,108 |
$6K |
| 86376 |
|
821 |
816 |
$6K |
| T1015 |
Clinic visit/encounter, all-inclusive |
399 |
372 |
$6K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
54 |
54 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
214 |
212 |
$6K |
| 83550 |
|
1,380 |
1,346 |
$6K |
| 87480 |
|
336 |
335 |
$6K |
| 87510 |
|
336 |
335 |
$6K |
| 87660 |
|
336 |
335 |
$6K |
| 73562 |
|
371 |
324 |
$5K |
| 83540 |
|
1,722 |
1,682 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,100 |
1,070 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
218 |
211 |
$5K |
| 87186 |
|
1,656 |
1,613 |
$5K |
| 74018 |
|
244 |
220 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,460 |
2,197 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
493 |
492 |
$5K |
| 82570 |
|
1,796 |
1,749 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
392 |
392 |
$4K |
| 84403 |
|
322 |
318 |
$4K |
| 82043 |
|
1,353 |
1,340 |
$4K |
| 81001 |
|
9,834 |
8,972 |
$4K |
| 11100 |
|
64 |
62 |
$3K |
| 83880 |
|
910 |
841 |
$3K |
| 80305 |
|
2,440 |
2,251 |
$3K |
| 86038 |
|
595 |
586 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
55 |
28 |
$3K |
| 85610 |
|
2,232 |
1,646 |
$3K |
| 83735 |
|
4,319 |
3,793 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
611 |
594 |
$3K |
| 87077 |
|
830 |
807 |
$3K |
| 86140 |
|
1,442 |
1,367 |
$2K |
| 73564 |
|
57 |
54 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
589 |
533 |
$2K |
| 81002 |
|
1,080 |
1,021 |
$2K |
| 87088 |
|
1,137 |
1,069 |
$2K |
| 99460 |
|
39 |
39 |
$2K |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
125 |
121 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
823 |
809 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
24 |
24 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
65 |
65 |
$2K |
| 87070 |
|
706 |
688 |
$2K |
| 94060 |
|
28 |
15 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
82 |
82 |
$2K |
| 85652 |
|
1,527 |
1,445 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
162 |
152 |
$1K |
| 83690 |
|
3,726 |
3,396 |
$1K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
13 |
13 |
$1K |
| 94726 |
|
26 |
26 |
$1K |
| 73502 |
|
88 |
78 |
$1K |
| 81025 |
|
4,400 |
4,095 |
$1K |
| 84402 |
|
97 |
96 |
$1K |
| 11102 |
|
24 |
24 |
$1K |
| 84702 |
|
257 |
190 |
$1K |
| 86780 |
|
159 |
159 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
344 |
342 |
$1K |
| 87631 |
|
126 |
125 |
$1K |
| 84100 |
|
2,625 |
2,339 |
$937.61 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
15 |
13 |
$851.19 |
| 72072 |
|
24 |
24 |
$838.61 |
| 74019 |
|
135 |
131 |
$818.34 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
73 |
73 |
$769.84 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
18 |
12 |
$697.12 |
| 87075 |
|
366 |
336 |
$647.18 |
| 84153 |
|
63 |
63 |
$597.52 |
| 83655 |
|
69 |
69 |
$596.48 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
65 |
61 |
$576.71 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
44 |
44 |
$574.66 |
| 87040 |
|
237 |
228 |
$568.03 |
| 87205 |
|
435 |
422 |
$498.16 |
| 86803 |
|
66 |
65 |
$479.44 |
| 83001 |
|
40 |
40 |
$381.03 |
| 84146 |
|
33 |
33 |
$303.81 |
| 85730 |
|
455 |
414 |
$298.53 |
| 82670 |
|
20 |
20 |
$263.40 |
| 86812 |
|
19 |
19 |
$239.88 |
| 73140 |
|
25 |
24 |
$237.26 |
| 90686 |
|
42 |
42 |
$234.96 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13 |
13 |
$227.12 |
| 86200 |
|
34 |
34 |
$213.09 |
| 84484 |
|
2,703 |
2,024 |
$204.86 |
| 90715 |
|
30 |
30 |
$194.04 |
| 73560 |
|
14 |
12 |
$192.56 |
| 87522 |
Neg quan hep c or qual rna |
12 |
12 |
$190.03 |
| 85379 |
|
468 |
455 |
$189.12 |
| 83002 |
|
18 |
18 |
$186.24 |
| 86431 |
|
69 |
68 |
$184.36 |
| 87340 |
|
71 |
70 |
$176.74 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,035 |
738 |
$164.53 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
30 |
29 |
$160.43 |
| 86618 |
|
18 |
18 |
$131.15 |
| 86850 |
|
225 |
217 |
$111.69 |
| 83605 |
|
1,734 |
1,547 |
$111.07 |
| 82805 |
|
187 |
173 |
$89.17 |
| 86706 |
|
26 |
26 |
$87.75 |
| 86901 |
|
485 |
454 |
$84.48 |
| 83525 |
|
16 |
16 |
$83.97 |
| 72040 |
|
13 |
13 |
$83.58 |
| 94729 |
|
40 |
27 |
$72.92 |
| 82565 |
|
79 |
79 |
$72.76 |
| 82150 |
|
13 |
12 |
$46.88 |
| 86060 |
|
13 |
12 |
$39.14 |
| 82248 |
|
13 |
13 |
$37.20 |
| 80076 |
|
12 |
12 |
$21.93 |
| 82077 |
|
995 |
892 |
$21.43 |
| 84480 |
|
12 |
12 |
$16.60 |
| 94664 |
|
87 |
86 |
$15.32 |
| 87210 |
|
12 |
12 |
$14.80 |
| 82375 |
|
189 |
175 |
$13.95 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,787 |
5,369 |
$12.63 |
| 83050 |
|
188 |
174 |
$9.29 |
| 84436 |
|
12 |
12 |
$8.04 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,704 |
4,372 |
$7.46 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,685 |
3,487 |
$5.33 |
| 84520 |
|
14 |
14 |
$4.96 |
| 84703 |
|
15 |
15 |
$4.11 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,991 |
3,091 |
$3.71 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,448 |
5,677 |
$2.76 |
| 3074F |
|
65 |
62 |
$0.16 |
| 3078F |
|
33 |
31 |
$0.08 |
| 36416 |
|
1,916 |
1,563 |
$0.01 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
649 |
559 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
3,218 |
2,912 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
500 |
323 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
14 |
14 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,290 |
1,181 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
170 |
134 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
65 |
63 |
$0.00 |
| 96376 |
|
508 |
378 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
41 |
36 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
76 |
76 |
$0.00 |
| 1101F |
|
82 |
81 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
14 |
13 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
43 |
42 |
$0.00 |
| A9270 |
Non-covered item or service |
60 |
28 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
12 |
12 |
$0.00 |
| 94760 |
|
14 |
14 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
12 |
12 |
$0.00 |
| 80050 |
General health panel |
32 |
31 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
974 |
871 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,097 |
1,060 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
328 |
235 |
$0.00 |
| 80179 |
|
316 |
286 |
$0.00 |
| 3288F |
|
82 |
81 |
$0.00 |
| 80143 |
|
355 |
318 |
$0.00 |
| 73590 |
|
12 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
12 |
12 |
$0.00 |
| 90461 |
|
16 |
16 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
12 |
12 |
$0.00 |
| 93017 |
|
12 |
12 |
$0.00 |
| 87634 |
|
26 |
26 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
46 |
45 |
$0.00 |
| 99051 |
|
14 |
13 |
$0.00 |